ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Indonesia adopts remdesivir as Malaysia shops for COVID vaccines

Southeast Asian neighbors reveal their latest steps to tackle pandemic

Indonesia is turning to the antiviral drug remdesivir as it struggles to cope with over 4,000 new COVID-19 patients per day.    © Reuters

JAKARTA/KUALA LUMPUR -- Indonesia and Malaysia are scurrying to beef up their capabilities to treat and stop COVID-19, as their infection trajectories raise alarm.

For Indonesia, which is still logging over 4,000 cases a day, Thursday brought the introduction of the antiviral drug known as remdesivir. The same day, Malaysia's science minister revealed his country is negotiating with numerous vaccine manufacturers, just hours before health authorities reported the highest daily infection count since June.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more